HCW Biologics Inc. Liquidation Value Calculator
HCW Biologics Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 142 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$13.14M | USD | ||
| accounts_receivable | ||||
| Receivables Net Current total ReceivablesNetCurrent |
$32,175 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$1.95M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$1.95M | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$21.06M | USD | ||
| liabilities_total | ||||
| Liabilities total | $21.76M | USD | ||
| long_term_debt | ||||
| Long Term Debt total LongTermDebt |
$0 | USD | ||
| long_term_investments | ||||
| Long Term Investments total LongTermInvestments |
$1.33M | USD | ||
| short_term_investments | ||||
| Short Term Investments total ShortTermInvestments |
$0 | USD | ||
Unmapped Tags (129)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $118,000 | USD | ||
| Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent | $1.11M | USD | ||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $4.18M | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $111.28M | USD | ||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings | $14.34M | USD | ||
| Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued | $14.95M | USD | ||
| Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs | $0 | USD | ||
| Assets Assets | $24.52M | USD | ||
| Assets Current AssetsCurrent | $2.28M | USD | ||
| Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid | $0 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $250.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $3.28M | shares | ||
| Common Stock Value CommonStockValue | $328 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $27.45M | USD | ||
| Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet | $0 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | $3.05M | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards | $1.71M | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $1.70M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $27.43M | USD | ||
| Dividends Common Stock Stock DividendsCommonStockStock | $14.34M | USD | ||
| Gain Loss On Investments GainLossOnInvestments | $-273,422 | USD | ||
| Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt | $5.46M | USD | ||
| Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse | $0 | USD | ||
| Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf | $1.50M | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $24.52M | USD | ||
| Other Assets Current OtherAssetsCurrent | $77,564 | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $28,476 | USD | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $25.06M | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $20.88M | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-108.52M | USD | ||
| Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | $4.21M | USD | ||
| Stockholders Equity StockholdersEquity | $2.76M | USD | ||
| Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount | $1.20M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $768,623 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-2.72M | USD | ||
| Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet | $24,897 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $959,388 | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | $23,697 | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $-3.47M | USD | ||
| Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable | $-550,026 | USD | ||
| Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi | $-273,422 | USD | ||
| Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability | $0 | USD | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | $-141,989 | USD | ||
| Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue | $49,316 | USD | ||
| Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | $49,316 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $10.67M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $0 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-13.39M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $1.21M | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $0 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $5.49M | USD | ||
| Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt | $150,000 | USD | ||
| Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants | $3.82M | USD | ||
| Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt | $-127,623 | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $0 | USD | ||
| Share Based Compensation ShareBasedCompensation | $768,623 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | $1 | pure | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | $0 | pure | ||
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $42,965 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $134 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | $1,654 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | $160 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | $95 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $400 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | $2 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | $0 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $44,193 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $132 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | $8 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | $83 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $4 | USD/shares | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $3.19M | shares | ||
| Cost Of Revenue CostOfRevenue | $43,386 | USD | ||
| Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment | $2.96M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | $64,758 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts | $1.33M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements | $2.20M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-11 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-11 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | $0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $7.70M | USD | ||
| Gross Profit GrossProfit | $10,846 | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-7.96M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $1.02M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $-1.67M | USD | ||
| Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther | $144,120 | USD | ||
| Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments | $-5,962 | USD | ||
| Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch | $-187,192 | USD | ||
| Interest Expense InterestExpense | $845,051 | USD | ||
| Net Income Loss NetIncomeLoss | $-7.96M | USD | ||
| Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic | $-22.30M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $0 | USD | ||
| Operating Expenses OperatingExpenses | $13.17M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-13.16M | USD | ||
| Other Operating Income Expense Net OtherOperatingIncomeExpenseNet | $68,376 | USD | ||
| Other Research And Development Expense OtherResearchAndDevelopmentExpense | $270,016 | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $222,156 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $5.44M | USD | ||
| Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax | $54,232 | USD | ||
| Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | $0 | USD | ||
| Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | $0 | USD | ||
| Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued | $0 | USD | ||
| Area Of Land AreaOfLand | $12,250 | sqft | ||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | $-1.06M | USD | ||
| Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability | $692,531 | USD | ||
| Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent | $692,531 | USD | ||
| Contractual Obligation ContractualObligation | $396,100 | USD | ||
| Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount | $127,295 | USD | ||
| Depreciation Depreciation | $507,021 | USD | ||
| Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet | $1.04M | USD | ||
| Fair Value Net Asset Liability FairValueNetAssetLiability | $2.24M | USD | ||
| Interest Paid Net InterestPaidNet | $601,661 | USD | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | Segment | ||
| Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction | $4.50M | USD | ||
| Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised | $200 | shares | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $-269,680 | USD | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $1,654 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.